Skip to content

Clinical trials

Phase 4 Atrial Fibrillation trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 4 Country / region: Russia Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20101
20111
20151
20161
20171
20181
20222
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status3
Enrolling by invitation1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biotronik SE & Co. KG1
Boehringer Ingelheim1
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health1
Irina Ermolaeva1
Medtronic BRC1
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation1
Pirogov Russian National Research Medical University1
Research Institute for Complex Problems of Cardiovascular Diseases, Russia1
Tomsk Cardiology Research Institute1
Tomsk National Research Medical Center of the Russian Academy of Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation12
Heart Failure2
Coronary Artery Disease1
Diabetes Mellitus, Type 21
Mitral Valve Insufficiency1
Mitral Valve Stenosis1
Renal Insufficiency, Chronic1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.